NO20082354L - Nye sykliske forbindelser - Google Patents

Nye sykliske forbindelser

Info

Publication number
NO20082354L
NO20082354L NO20082354A NO20082354A NO20082354L NO 20082354 L NO20082354 L NO 20082354L NO 20082354 A NO20082354 A NO 20082354A NO 20082354 A NO20082354 A NO 20082354A NO 20082354 L NO20082354 L NO 20082354L
Authority
NO
Norway
Prior art keywords
hepatitis
cyclic compounds
new cyclic
virus
replication
Prior art date
Application number
NO20082354A
Other languages
English (en)
Norwegian (no)
Inventor
Masahiro Neya
Seiji Yoshimura
Kazunori Kamijyo
Takuya Makino
Minoru Yasuda
Toshio Yamanaka
Eisaku Tsujii
Yukiko Yamagishi
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of NO20082354L publication Critical patent/NO20082354L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20082354A 2005-10-26 2008-05-23 Nye sykliske forbindelser NO20082354L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73001105P 2005-10-26 2005-10-26
US75120405P 2005-12-19 2005-12-19
PCT/JP2006/321924 WO2007049803A1 (en) 2005-10-26 2006-10-26 New cyclic peptide compounds

Publications (1)

Publication Number Publication Date
NO20082354L true NO20082354L (no) 2008-07-01

Family

ID=37847219

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082354A NO20082354L (no) 2005-10-26 2008-05-23 Nye sykliske forbindelser

Country Status (17)

Country Link
US (2) US7872097B2 (https=)
EP (1) EP1957518B1 (https=)
JP (1) JP5218051B2 (https=)
KR (1) KR101273681B1 (https=)
CN (1) CN101305019B (https=)
AU (1) AU2006306974B2 (https=)
BR (1) BRPI0617781A2 (https=)
CA (1) CA2623898C (https=)
ES (1) ES2557477T3 (https=)
IL (1) IL190286A0 (https=)
NO (1) NO20082354L (https=)
PL (1) PL1957518T3 (https=)
PT (1) PT1957518E (https=)
RU (1) RU2423377C2 (https=)
TW (1) TWI391403B (https=)
WO (1) WO2007049803A1 (https=)
ZA (1) ZA200803525B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100017547A (ko) 2007-05-02 2010-02-16 아스텔라스세이야쿠 가부시키가이샤 신규 시클릭 펩티드 화합물
CN102164947A (zh) * 2008-09-24 2011-08-24 安斯泰来制药有限公司 肽化合物及其制备方法
KR20110111321A (ko) * 2009-01-30 2011-10-10 이난타 파마슈티칼스, 인코포레이티드 C형 간염을 예방하거나 치료하기 위한 사이클로스포린 유사체
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
SG176085A1 (en) * 2009-05-15 2011-12-29 Stichting Nl Kanker Inst Lysine compounds and their use in site- and chemoselective modification of peptides and proteins
US8349312B2 (en) 2009-07-09 2013-01-08 Enanta Pharmaceuticals, Inc. Proline substituted cyclosporin analogues
US8367053B2 (en) 2009-07-09 2013-02-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8685917B2 (en) 2009-07-09 2014-04-01 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
WO2011082289A1 (en) * 2009-12-30 2011-07-07 Scynexis Inc. Cyclosporine analogues
JP2015529206A (ja) 2012-08-25 2015-10-05 ザ・ジョンズ・ホプキンス・ユニバーシティ Gapdhカスケードインヒビター化合物ならびに使用の方法および精神病を含むストレス誘導障害の処置
EP2900684A2 (en) 2012-09-29 2015-08-05 Novartis AG Cyclic peptides and use as medicines
WO2014085623A1 (en) 2012-11-28 2014-06-05 Enanta Pharmaceuticals, Inc. Novel [n-me-4-hydroxyleucine]-9-cyclosporin analogues
JP2016538317A (ja) 2013-08-26 2016-12-08 エナンタ ファーマシューティカルズ インコーポレイテッド C型肝炎を防止または治療するための新規シクロスポリン類似体
US9669095B2 (en) 2014-11-03 2017-06-06 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis C infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05271267A (ja) * 1991-04-23 1993-10-19 Fujisawa Pharmaceut Co Ltd Fr901459物質、その製法及び用途
AU759480B2 (en) 1998-07-01 2003-04-17 Debiopharm S.A. Novel cyclosporin with improved activity profile
AU2001295966A1 (en) * 2000-10-19 2002-04-29 Fujisawa Pharmaceutical Co. Ltd. Cell damage inhibitor
CN100344648C (zh) * 2001-10-19 2007-10-24 伊索泰克尼卡股份有限公司 环孢菌素类似物混合物及其在制备免疫调节剂中的用途
GB0320638D0 (en) 2003-09-03 2003-10-01 Novartis Ag Organic compounds
JP2007015926A (ja) * 2003-10-06 2007-01-25 Fujisawa Pharmaceut Co Ltd C型肝炎治療剤
DK1793844T3 (da) 2004-10-01 2011-03-21 Debiopharm Sa Anvendelse af [D-MeAla]3-[EtVal]4-cyklosporin til behandling af hepatitis C-infektion
SI1802650T1 (sl) 2004-10-01 2012-03-30 Scynexis Inc Eter in tioeter substituirani ciklosporinski derivati za zdravljenje in preventivo pred infekcijami s hepatitisom c
ES2314731T3 (es) * 2004-11-22 2009-03-16 Astellas Pharma Inc. Analogo de ciclosporina.

Also Published As

Publication number Publication date
JP2009513562A (ja) 2009-04-02
US8252895B2 (en) 2012-08-28
PL1957518T3 (pl) 2016-07-29
RU2008116674A (ru) 2009-10-27
CN101305019A (zh) 2008-11-12
KR101273681B1 (ko) 2013-06-25
TW200732351A (en) 2007-09-01
CN101305019B (zh) 2012-12-12
US7872097B2 (en) 2011-01-18
IL190286A0 (en) 2011-08-01
EP1957518A1 (en) 2008-08-20
RU2423377C2 (ru) 2011-07-10
ES2557477T3 (es) 2016-01-26
CA2623898C (en) 2013-12-24
EP1957518B1 (en) 2015-12-09
WO2007049803A1 (en) 2007-05-03
AU2006306974A1 (en) 2007-05-03
AU2006306974B2 (en) 2011-09-22
US20100286033A1 (en) 2010-11-11
US20090170755A1 (en) 2009-07-02
PT1957518E (pt) 2016-02-26
CA2623898A1 (en) 2007-05-03
JP5218051B2 (ja) 2013-06-26
KR20080065297A (ko) 2008-07-11
BRPI0617781A2 (pt) 2011-08-09
ZA200803525B (en) 2009-08-26
TWI391403B (zh) 2013-04-01

Similar Documents

Publication Publication Date Title
NO20082354L (no) Nye sykliske forbindelser
MX2009011512A (es) Nuevos compuestos peptidos ciclicos.
DE60314495D1 (de) Aminosäuresequenzen die die fähigkeit besitzen, die durchdringung durch eine biologische barriere erleichtern
CY1112115T1 (el) Παραγωγα φαινοξυοξικου οξεος χρησιμα για τη θεραπευτικη αντιμετωπιση ασθενειων του αναπνευστικου
CY1110812T1 (el) Παραγωγα διφαινυλοξυοξικου οξεος για τη θεραπεια αναπνευστικων διαταραχων
CY1110318T1 (el) Παραγωγα φαινοξυοξικου οξεος
BRPI0718586A2 (pt) Composto, processo para a sua preparação, composição farmacêutica contendo o mesmo, usos deste e método de tratamento ou prevenção de doenças
NO20080745L (no) Nye peptider for anvendelse i behandling av fedme
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
ATE405564T1 (de) 1h-imidazoä4,5-cüchinolinderivate zur behandlung von protein kinase-abhängigen krankheiten
NO20073665L (no) 2-fenoksy-N-(1,3,4-tiadizol-2-yl) Pyridin-3-aminderivater og beslektede forbindelser som P2Y1 reseptor inhibitorer for behandling av tromboemboliforstyrrelser
CY1107146T1 (el) Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad)
NO20072290L (no) Organiske forbindelser.
WO2005002526A3 (en) Method and compositions for treatment of viral infections
BRPI0416287A (pt) compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que são moduladas por inibidores de accß e sua utilização
BRPI0513819A (pt) inibidores de hsp90
WO2008124176A3 (en) Soluble and membrane-anchored forms of lassa virus subunit proteins
NO20070665L (no) Derivater av 1-fenylalkankarboksylsyrer for behandlingen av neurodegenerative sykdommer
NO330888B1 (no) Benzensylfonamidderivater, fremgangsmate for fremstilling av slike, terapeutisk preparatinneholdende slike samt anvendelse av slike for fremstilling av preparat for behandling av sykdom
BRPI0410837A (pt) composto, composição farmacêutica, e, método para tratar ou prevenir uma doença ou condição
TW200510352A (en) Cycloalkyl substituted amino acid derivatives, processes for their freparation and their use as pharmaceuticals
BRPI0415781A (pt) método para o tratamento de diabetes em um paciente e kit farmacêutico
ATE508749T1 (de) Antidepressiva zur prophylaxe und therapie von zystischer fibrose
BRPI0911159A2 (pt) compostos derivados de ácido 4-dimetilaminobutírico, processo para a sua preparação, composições farmacêuticas que os compreendem, método para o tratamento terapêutico ou profilático de enfermidades que são moduladas por inibidres de cpt2 e uso destes compostos

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application